Surgical Innovations Group plc

AIM:SUN 주식 보고서

시가총액: UK£5.1m

Surgical Innovations Group 관리

관리 기준 확인 3/4

Surgical Innovations Group CEO는 David Marsh, Feb2019 에 임명되었습니다 의 임기는 5.75 년입니다. 총 연간 보상은 £ 219.00K, 94.1% 로 구성됩니다. 94.1% 급여 및 5.9% 보너스(회사 주식 및 옵션 포함). 는 £ 173.59K 가치에 해당하는 회사 주식의 3.38% 직접 소유합니다. 173.59K. 경영진과 이사회의 평균 재임 기간은 각각 3.8 년과 11.4 년입니다.

주요 정보

David Marsh

최고 경영자

UK£219.0k

총 보상

CEO 급여 비율94.1%
CEO 임기5.8yrs
CEO 소유권3.4%
경영진 평균 재임 기간3.8yrs
이사회 평균 재임 기간11.4yrs

최근 관리 업데이트

Recent updates

Surgical Innovations Group plc (LON:SUN) Shares Fly 63% But Investors Aren't Buying For Growth

Jul 11
Surgical Innovations Group plc (LON:SUN) Shares Fly 63% But Investors Aren't Buying For Growth

Surgical Innovations Group plc's (LON:SUN) Share Price Is Matching Sentiment Around Its Revenues

Apr 19
Surgical Innovations Group plc's (LON:SUN) Share Price Is Matching Sentiment Around Its Revenues

Investors Don't See Light At End Of Surgical Innovations Group plc's (LON:SUN) Tunnel And Push Stock Down 33%

Dec 29
Investors Don't See Light At End Of Surgical Innovations Group plc's (LON:SUN) Tunnel And Push Stock Down 33%

Returns On Capital At Surgical Innovations Group (LON:SUN) Paint A Concerning Picture

Sep 07
Returns On Capital At Surgical Innovations Group (LON:SUN) Paint A Concerning Picture

Surgical Innovations Group (LON:SUN) Has Some Difficulty Using Its Capital Effectively

May 26
Surgical Innovations Group (LON:SUN) Has Some Difficulty Using Its Capital Effectively

Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?

Jun 15
Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?

Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?

Sep 24
Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?

Health Check: How Prudently Does Surgical Innovations Group (LON:SUN) Use Debt?

Mar 29
Health Check: How Prudently Does Surgical Innovations Group (LON:SUN) Use Debt?

CEO 보상 분석

David Marsh 의 보수는 Surgical Innovations Group 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024n/an/a

-UK£622k

Mar 31 2024n/an/a

-UK£565k

Dec 31 2023UK£219kUK£206k

-UK£509k

Sep 30 2023n/an/a

-UK£302k

Jun 30 2023n/an/a

-UK£96k

Mar 31 2023n/an/a

UK£84k

Dec 31 2022UK£211kUK£198k

UK£264k

Sep 30 2022n/an/a

-UK£56k

Jun 30 2022n/an/a

-UK£376k

Mar 31 2022n/an/a

-UK£416k

Dec 31 2021UK£201kUK£187k

-UK£456k

Sep 30 2021n/an/a

-UK£635k

Jun 30 2021n/an/a

-UK£815k

Mar 31 2021n/an/a

-UK£2m

Dec 31 2020UK£175kUK£162k

-UK£3m

Sep 30 2020n/an/a

-UK£4m

Jun 30 2020n/an/a

-UK£5m

Mar 31 2020n/an/a

-UK£4m

Dec 31 2019UK£186kUK£173k

-UK£3m

Sep 30 2019n/an/a

-UK£1m

Jun 30 2019n/an/a

UK£300k

Mar 31 2019n/an/a

UK£513k

Dec 31 2018UK£161kUK£122k

UK£725k

Sep 30 2018n/an/a

UK£521k

Jun 30 2018n/an/a

UK£317k

Mar 31 2018n/an/a

UK£403k

Dec 31 2017UK£126kUK£51k

UK£488k

보상 대 시장: David 의 총 보상 ($USD 274.08K )은 UK 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 356.31K ).

보상과 수익: 회사가 수익성이 없는 동안 David 의 보상이 증가했습니다.

CEO

David Marsh (60 yo)

5.8yrs

테뉴어

UK£219,000

보상

Mr. David John Marsh has been the Chief Executive Officer of Surgical Innovations Group plc since February 28, 2019. Mr. Marsh served as the Group Commercial Director at Surgical Innovations Group plc on t...

리더십 팀

이름위치테뉴어보상소유권
David Marsh
CEO & Director5.8yrsUK£219.00k3.38%
£ 173.6k
Christopher Martin
CFO & Executive Directorless than a year데이터 없음데이터 없음
Alex Hogg
Operations Director5.7yrs데이터 없음데이터 없음
Stephen Seed
Chief Compliance Officerno data데이터 없음데이터 없음
Julia Taylor
HR Director1.3yrs데이터 없음데이터 없음
Damian Donnelly
Chief Commercial Officer3.8yrs데이터 없음데이터 없음

3.8yrs

평균 재임 기간

경험이 풍부한 관리: SUN 의 관리팀은 경험 ( 3.8 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
David Marsh
CEO & Director7.3yrsUK£219.00k3.38%
£ 173.6k
Christopher Martin
CFO & Executive Directorless than a year데이터 없음데이터 없음
Jonathan Glenn
Senior Independent Non-Executive Director & Chairman1.5yrsUK£24.00k0.14%
£ 7.2k
Michael McMahon
Member of Clinical Advisory Boardno dataUK£19.00k데이터 없음
Ian Brayshaw
Member of the Clinical Advisory Boardno data데이터 없음데이터 없음
Philippe Grange
Member of the Clinical Advisory Boardno data데이터 없음데이터 없음
Keyvan Djamarani
Independent Non-executive Directorless than a yearUK£2.00k데이터 없음
Marco Adamo
Member of the Clinical Advisory Board13.8yrs데이터 없음데이터 없음
James Halstead
Member of the Clinical Advisory Board12.8yrs데이터 없음데이터 없음
Chris Sutton
Member of the Clinical Advisory Board12.8yrs데이터 없음데이터 없음
John Griffith
Member of the Clinical Advisory Board11.9yrs데이터 없음데이터 없음
Henrik Steinbrecher
Member of the Clinical Advisory Board11.4yrs데이터 없음데이터 없음

11.4yrs

평균 재임 기간

60yo

평균 연령

경험이 풍부한 이사회: SUN 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 11.4 년).